GH Research (GHRS) Director Hanley Receives 2,202-Share Award

What Happened

• Hanley Dermot John, a director of GH Research plc (GHRS), was granted 2,202 derivative shares/options on August 11, 2026. The award shows an acquisition price of $0 (i.e., a non‑cash grant). According to the filing, the options are immediately fully vested but are not exercisable until August 11, 2028. This is an award/grant (compensation), not an open‑market purchase or sale.

Key Details

• Transaction date: 2026-08-11
• Transaction type: Award/Grant of derivative securities (code A)
• Shares/options granted: 2,202
• Price paid: $0 (no cash paid)
• Vesting/exercise restriction: Immediately fully vested; not exercisable until 2028-08-11 (footnote)
• Shares owned after transaction: Not reported in the provided filing details
• Timeliness: Filing date 2026-08-13 for a transaction on 2026-08-11 (appears timely based on the provided dates)

Context

• These are derivative awards (options) that give the holder the right to acquire shares in the future; because they are not exercisable until 2028, Hanley cannot convert them into common stock immediately. Such grants are a common form of director compensation and do not represent an immediate purchase or sale of GHRS shares.